The National Cancer Institute (NCI) offers its Outstanding Investigator Award (R35) to provide long-term funding for highly accomplished investigators. This grant supports researchers with exceptional records in cancer research who propose groundbreaking projects. The OIA encourages taking greater risks, pursuing adventurous inquiries, or developing new techniques. It ensures extended funding stability for projects of unusual potential, fostering work that breaks new ground or extends discoveries. The purpose is to lead to breakthroughs that significantly advance biomedical, behavioral, or clinical cancer research, making a profound impact on the field.
Opportunity ID: 335827
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-333 |
| Funding Opportunity Title: | NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 20, 2021 |
| Last Updated Date: | Sep 20, 2021 |
| Original Closing Date for Applications: | Nov 04, 2021 |
| Current Closing Date for Applications: | Nov 04, 2021 |
| Archive Date: | Dec 10, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $600,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts City or township governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) State governments Public housing authorities/Indian housing authorities County governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research. The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA. It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-333.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00269019 | Oct 04, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
335827 RR_SF424_2_0-2.0.pdf
335827 PHS398_CoverPageSupplement_5_0-5.0.pdf
335827 RR_OtherProjectInfo_1_4-1.4.pdf
335827 PerformanceSite_2_0-2.0.pdf
335827 RR_KeyPersonExpanded_2_0-2.0.pdf
335827 RR_Budget10_1_4-1.4.pdf
335827 PHS398_ResearchPlan_4_0-4.0.pdf
335827 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335827 RR_SubawardBudget10_30_1_4-1.4.pdf
335827 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
